This raises the possibility that in antigen presenting cells, such as macrophages, which are targets for HIV-1 infection in vivo, tetherin-restricted virions could be targeted for proteolytic destruction in phagosomes and viral components processed for antigen presentation. The gene discussed is BST2; the disease is HIV-1 infection.